First Eagle Investment Management’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
BBHC
First Eagle Investment Management's NVS Position: Q1 2018 in Review
First Eagle Investment Management sold out of Novartis (NVS) in Q1 2018, closing a stake of 17,686 shares — an estimated $1.33M sold.
First Eagle Investment Management first reported a position in NVS in Q2 2013 and held it in 19 quarters. The position peaked at $1.33M in Q4 2017. 1,013 funds tracked by Wall St. Rank hold NVS as of Q1 2018.
- First Eagle Investment Management reported no remaining Novartis position as of Q1 2018 after selling out during the quarter.
- First Eagle Investment Management sold 17,686 Novartis shares in Q1 2018, an estimated $1.33M.
- First Eagle Investment Management first reported a position in Novartis in Q2 2013 and held it in 19 quarters.
- First Eagle Investment Management's Novartis position peaked at $1.33M in Q4 2017.
- 1,013 funds tracked by Wall St. Rank held Novartis as of Q1 2018.
Based on First Eagle Investment Management's 13F filing for Q1 2018, filed 4 May 2018.